Loading clinical trials...
Loading clinical trials...
A Clinico-biological Database on Atypical Venous Thrombosis in the Context of anticovid19 Vaccination
In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.
In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after anti-Covid vaccination.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
CHU lille
Lille, France
Start Date
April 2, 2021
Primary Completion Date
May 1, 2023
Completion Date
May 1, 2023
Last Updated
January 18, 2023
100
ESTIMATED participants
Retrospective data and biological samples
OTHER
Lead Sponsor
University Hospital, Lille
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232